![CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-00007-0/MediaObjects/41598_2021_7_Fig1_HTML.png)
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
![B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Far3908/MediaObjects/13075_2013_Article_3910_Fig1_HTML.jpg)
B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text
![Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations](https://www.frontiersin.org/files/Articles/484200/fimmu-10-02458-HTML/image_m/fimmu-10-02458-g001.jpg)
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
![Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab](https://www.mdpi.com/brainsci/brainsci-10-00758/article_deploy/html/images/brainsci-10-00758-g001.png)
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
![IJMS | Free Full-Text | Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma IJMS | Free Full-Text | Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma](https://www.mdpi.com/ijms/ijms-23-01501/article_deploy/html/images/ijms-23-01501-g001.png)
IJMS | Free Full-Text | Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma
![Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram](https://www.researchgate.net/publication/323911459/figure/fig1/AS:606619687714816@1521640812005/Summary-of-CD19-and-CD20-expression-during-B-cell-development-CD19-expression-is.png)
Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
![Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model](https://www.frontiersin.org/files/Articles/478945/fimmu-10-02680-HTML/image_m/fimmu-10-02680-g001.jpg)
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
![B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-022-00619-z/MediaObjects/41571_2022_619_Fig1_HTML.png)